Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Valink Therapeutics Raises $11.8M Pre‑A Round Led by Redalpine
SeedVenture Capital

Valink Therapeutics Raises $11.8M Pre‑A Round Led by Redalpine

•October 20, 2025
•Oct 20, 2025
0

Participants

Valink

Valink

company

LongeVC

LongeVC

investor

RV Invest

RV Invest

investor

P53 Therapeutics

P53 Therapeutics

investor

redalpine

redalpine

investor

University of Oxford

University of Oxford

investor

Deal Summary

Cambridge-based Valink Therapeutics closed an $11.8M pre‑A financing to advance its bispecific antibody-drug conjugates and oncology programs. The round was led by redalpine with participation from LongeVC, Oxford Science Enterprises and existing backers RV Invest and p53 Invest.

0

Comments

Want to join the conversation?

Loading comments...